Jove
Visualize
Contact Us

Related Experiment Videos

Collagenous colitis and lymphocytic colitis.

W J Tremaine1

  • 1Mayo Clinic, Rochester, Minnesota 55905, USA. tremaine.william@mayo.edu

Journal of Clinical Gastroenterology
|April 25, 2000
PubMed
Summary

Microscopic colitis, including collagenous colitis and lymphocytic colitis, are poorly understood inflammatory bowel diseases. While treatments are symptomatic, these conditions rarely require surgery and do not increase cancer risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: the definition of budesonide dependence in microscopic colitis-authors' reply.

Alimentary pharmacology & therapeutics·2017
Same author

Immune modulator therapy for microscopic colitis in a case series of 73 patients.

Alimentary pharmacology & therapeutics·2017
Same author

Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice.

Alimentary pharmacology & therapeutics·2015
Same author

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.

Alimentary pharmacology & therapeutics·2014
Same author

Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease.

Alimentary pharmacology & therapeutics·2013
Same author

Issues in the development of practice guidelines for inflammatory bowel disease.

Inflammatory bowel diseases·2013
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Gastroenterology and Internal Medicine
  • Inflammatory Bowel Disease (IBD) Research

Background:

  • Idiopathic microscopic colitis encompasses collagenous colitis and lymphocytic colitis, the least understood IBD forms.
  • These conditions share clinical and histologic traits, yet distinctions remain debated.
  • Current treatments are empirical and symptomatic, with limited understanding of underlying mechanisms.

Purpose of the Study:

  • To elucidate the characteristics and management of collagenous colitis and lymphocytic colitis.
  • To compare and contrast these conditions with other forms of inflammatory bowel disease.
  • To assess the long-term outcomes, including malignancy risk and surgical necessity.

Main Methods:

  • Review of clinical and histologic features of collagenous colitis and lymphocytic colitis.
  • Analysis of treatment responses, including symptomatic and empirical therapies like bismuth subsalicylate.
  • Comparison of disease course and management strategies with ulcerative colitis and Crohn's disease.

Main Results:

  • Collagenous colitis and lymphocytic colitis are distinct yet related entities within IBD.
  • Bismuth subsalicylate shows efficacy in a subset of patients; other treatments are symptomatic.
  • Surgical intervention (ileostomy with or without colectomy) is rarely needed and curative for severe, refractory cases.

Conclusions:

  • Collagenous colitis and lymphocytic colitis represent unique challenges in IBD management.
  • These conditions are not associated with an increased risk of malignancy.
  • Further research is needed to understand their distinct pathophysiology and optimize targeted therapies.

Related Experiment Videos